Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
5.36
+0.14 (2.68%)
At close: Dec 5, 2025, 4:00 PM EST
5.33
-0.03 (-0.56%)
After-hours: Dec 5, 2025, 4:10 PM EST
Generation Bio Co. Market Cap
Generation Bio Co. has a market cap or net worth of $35.91 million as of December 5, 2025. Its market cap has decreased by -62.40% in one year.
Market Cap
35.91M
Enterprise Value
-27.61M
1-Year Change
-62.40%
Ranking
Category
Stock Price
$5.36
Market Cap Chart
Since June 12, 2020, Generation Bio Co.'s market cap has decreased from $1.07B to $35.91M, a decrease of -96.65%. That is a compound annual growth rate of -46.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 35.17M | -50.32% |
| Dec 31, 2024 | 70.80M | -35.06% |
| Dec 29, 2023 | 109.03M | -53.31% |
| Dec 30, 2022 | 233.53M | -41.89% |
| Dec 31, 2021 | 401.89M | -68.88% |
| Dec 31, 2020 | 1.29B | 20.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |